Regeneron Pharmaceuticals
REGN
REGN
1,171 hedge funds and large institutions have $75B invested in Regeneron Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 397 increasing their positions, 444 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,171
Holders Change
+12
Holders Change %
+1.04%
% of All Funds
18.67%
Holding in Top 10
29
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.57%
% of All Funds
0.46%
New
111
Increased
397
Reduced
444
Closed
87
Calls
$1.43B
Puts
$1.61B
Net Calls
-$183M
Net Calls Change
+$45.7M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$696M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$551M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$73.2M |
| 4 |
D.E. Shaw & Co
New York
|
+$68M |
| 5 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
+$65.3M |
Top Sellers
| 1 |
EWA
EP Wealth Advisors
Torrance,
California
|
-$467M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$365M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$259M |
| 4 |
BlackRock
New York
|
-$173M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$136M |
